Aryx Therapeutics I Stock Shares Owned By Insiders
| ARYXDelisted Stock | USD 0.0005 0.00 0.00% |
Aryx Therapeutics I fundamentals help investors to digest information that contributes to Aryx Therapeutics' financial success or failures. It also enables traders to predict the movement of Aryx Pink Sheet. The fundamental analysis module provides a way to measure Aryx Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aryx Therapeutics pink sheet.
Aryx |
Aryx Therapeutics I Company Shares Owned By Insiders Analysis
Aryx Therapeutics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 0.0% of Aryx Therapeutics I are shares owned by insiders. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The shares owned by insiders for all United States stocks is 100.0% higher than that of the company.
Aryx Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aryx Therapeutics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Aryx Therapeutics could also be used in its relative valuation, which is a method of valuing Aryx Therapeutics by comparing valuation metrics of similar companies.Aryx Therapeutics is currently under evaluation in shares owned by insiders category among its peers.
Aryx Fundamentals
| Return On Asset | -0.75 | ||||
| Current Valuation | 237.58 K | ||||
| Shares Outstanding | 33.46 M | ||||
| Shares Owned By Institutions | 0.14 % | ||||
| Number Of Shares Shorted | 89.05 K | ||||
| Price To Book | 37.83 X | ||||
| EBITDA | (14.18 M) | ||||
| Net Income | (33.17 M) | ||||
| Cash And Equivalents | 2.95 M | ||||
| Cash Per Share | 0.09 X | ||||
| Debt To Equity | (5.11) % | ||||
| Current Ratio | 0.47 X | ||||
| Book Value Per Share | (0.23) X | ||||
| Cash Flow From Operations | (34.97 M) | ||||
| Short Ratio | 0.79 X | ||||
| Earnings Per Share | (0.59) X | ||||
| Target Price | 1.5 | ||||
| Number Of Employees | 56 | ||||
| Beta | 0.0896 | ||||
| Market Capitalization | 237.58 K | ||||
| Total Asset | 12.41 M | ||||
| Retained Earnings | (187.11 M) | ||||
| Working Capital | 126 K | ||||
| Current Asset | 8.62 M | ||||
| Current Liabilities | 8.49 M | ||||
| Z Score | -24.3 | ||||
| Net Asset | 12.41 M |
About Aryx Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aryx Therapeutics I's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aryx Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aryx Therapeutics I based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Aryx Pink Sheet
If you are still planning to invest in Aryx Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aryx Therapeutics' history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |